IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms12948.html
   My bibliography  Save this article

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

Author

Listed:
  • Samuel A. J. Trammell

    (Carver College of Medicine, University of Iowa)

  • Mark S. Schmidt

    (Carver College of Medicine, University of Iowa)

  • Benjamin J. Weidemann

    (Carver College of Medicine, University of Iowa)

  • Philip Redpath

    (John King Laboratory, School of Pharmacy, Queens University Belfast)

  • Frank Jaksch

    (ChromaDex, Inc.)

  • Ryan W. Dellinger

    (ChromaDex, Inc.)

  • Zhonggang Li

    (Carver College of Medicine, University of Iowa)

  • E. Dale Abel

    (Carver College of Medicine, University of Iowa
    Carver College of Medicine, University of Iowa)

  • Marie E. Migaud

    (Carver College of Medicine, University of Iowa
    John King Laboratory, School of Pharmacy, Queens University Belfast)

  • Charles Brenner

    (Carver College of Medicine, University of Iowa
    Carver College of Medicine, University of Iowa)

Abstract

Nicotinamide riboside (NR) is in wide use as an NAD+ precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD+ metabolism in humans. We report that human blood NAD+ can rise as much as 2.7-fold with a single oral dose of NR in a pilot study of one individual, and that oral NR elevates mouse hepatic NAD+ with distinct and superior pharmacokinetics to those of nicotinic acid and nicotinamide. We further show that single doses of 100, 300 and 1,000 mg of NR produce dose-dependent increases in the blood NAD+ metabolome in the first clinical trial of NR pharmacokinetics in humans. We also report that nicotinic acid adenine dinucleotide (NAAD), which was not thought to be en route for the conversion of NR to NAD+, is formed from NR and discover that the rise in NAAD is a highly sensitive biomarker of effective NAD+ repletion.

Suggested Citation

  • Samuel A. J. Trammell & Mark S. Schmidt & Benjamin J. Weidemann & Philip Redpath & Frank Jaksch & Ryan W. Dellinger & Zhonggang Li & E. Dale Abel & Marie E. Migaud & Charles Brenner, 2016. "Nicotinamide riboside is uniquely and orally bioavailable in mice and humans," Nature Communications, Nature, vol. 7(1), pages 1-14, December.
    • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12948
    DOI: 10.1038/ncomms12948
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms12948
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms12948?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12948. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.